Suvoda 2022 Clinical Trials Surge 20% as it Expands Offerings to Include eConsent and eCOA
Company achieves Top Performer status in ISR IRT Benchmark Survey PHILADELPHIA, Jan. 18, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, surpassed 1,000 clinical trials in 2022 as study deployments surged nearly 20%,...
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs
TOKYO, Jan. 18, 2023 /PRNewswire/ -- Tanso Biosciences, a leading provider of functional assays for G-protein-coupled receptors (GPCRs), is thrilled to announce a major expansion of its assay platform. Building upon its already extensive coverage of 300 human GPCRs, Tanso Biosciences has added 250 mouse GPCRs to its platform, bringing the total coverage to an impressive 550 GPCRs....
CGTN: China’s COVID-19 vaccines proven safe, effective by trials and data
BEIJING, Jan. 17, 2023 /PRNewswire/ -- COVID-19 vaccines produced in China have been proven to be safe and effective by clinical trials and real-world data. The vaccines have helped save people in China and around the world, which is an irreversible accomplishment and cannot be challenged by denialists. Various options China is the only country with COVID-19 vaccines developed via...
Hybribio returns to Medlab Middle East 2023
GUANGZHOU, China, Jan. 17, 2023 /PRNewswire/ -- Medlab Middle East 2023 will be held at the World Trade Centre, Dubai, UAE from February 6 to 9. As one of the most well-known and professional exhibitions of trade platforms for the field of medical laboratory equipment and medical equipment, this expo draws more than 700 exhibitors from over 40 countries,...
NOVARAD PROVIDES FREE DIGITAL HEALTH RECORD SHARING TECHNOLOGY TO HOSPITALS IN DEVELOPING COUNTRIES
CryptoChart Lite Medical Image Sharing System Provides Secure Medical Imaging and Digital Records Transfer via Secure QR Code or Web Access Code SALT LAKE CITY, Jan. 17, 2023 /PRNewswire/ -- Novarad announced today its release of CryptoChart Lite, a web-based version of the healthcare company's CryptoChart medical image and report sharing system,...
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management
LePure Biotech is a leading provider of high-quality and innovative single-use bioprocessing solutions in China Proceeds will be used to continue to accelerate product innovation and advance LePure Biotech's go-to-market strategy SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Shanghai LePure Biotech Co., Ltd. ("LePure" or "LePure Biotech") announced the completion of its Series C financing from...
Health in Transportation, NuraLogix Release New Smartphone Face-Scanning Application Aimed at Uncovering Life-Threatening Health Concerns in Professional Drivers
ST. GEORGE, Utah, Jan. 17, 2023 /PRNewswire/ -- Health in Transportation, a health and wellness solution provider for the transportation industry, has partnered with health technology giant NuraLogix to deliver a revolutionary preventative health tool for drivers called CDL Health Scanner. Accessed through a specific URL on a smartphone, CDL Health Scanner's proprietary technology uses the smartphone's camera to...
Accuray Announces First Patient Treatments in New Zealand With the CyberKnife® System, the World’s Only Robotic Radiation Therapy Delivery Device
Auckland Radiation Oncology Selected the Latest-Generation CyberKnife S7™ System to Deliver Precise Treatments More Quickly, so Patients Can Rapidly Return to the Activities They Enjoy SUNNYVALE, Calif., Jan. 17, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Auckland Radiation Oncology (ARO) is the first center in New Zealand to treat...
Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC
World's first anti-PD-1 mAb for the first-line treatment of SCLC Making a new record with the median OS of 15.8 months in an international, multi-center, phase 3 clinical trial Granted orphan drug designations by the FDA and the EC, paving the way for international commercialization SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696. HK)...
Health supplement information app Pillwork set for launch in the first-half year
SEOUL, South Korea, Jan. 17, 2023 /PRNewswire/ -- Pillwork releases its app Pillwork that allows people to easily compare and purchase health supplements in the first-half year. Hybrid Healthcare startup PillWork The app is designed to help consumers gain a highly reliable information of health supplements for purchase. Users can check information and...
